Sean Bohen
PRESIDENT AND CEO · Olema Pharmaceuticals, Inc.
- 2024
- Feb 5, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Sean Bohen files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David C. Myles - $3.11M in OLMA purchases and sales in the last 12 months
- Shane William Charles Kovacs - $2.98M in OLMA purchases and sales in the last 12 months
- Shawnte Mitchell - $952K in OLMA purchases and sales in the last 12 months
- Cyrus Harmon - $662K in OLMA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sean Bohen?
Sean Bohen is a corporate insider, tracked as PRESIDENT AND CEO of Olema Pharmaceuticals, Inc. (OLMA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Sean Bohen last file a Form 4?
The most recent primary Form 4 on record is dated 5 February 2026, one of 2 filings going back to 2024.
Has Sean Bohen been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($986K) across all tracked filings.
